Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTirzepatide's cost in the UK private market varies by dose and provider, but any legitimate price should include a prescription following clinical assessment — it is a prescription-only medicine, and no regulated pharmacy can supply it any other way. Since Eli Lilly raised the UK list price on 1 September 2025, the highest-dose pen's list price rose from around £122 to around £330 for a four-week supply; typical private prices across providers now range roughly £149–£375 per month depending on the strength you're prescribed and what the provider includes. That range is wide, and the gap is not always about the medicine itself — it is often about what else is, or isn't, wrapped around it. A prescriber decides clinical suitability; a quoted price alone cannot tell you whether treatment is right for you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The list price set by the manufacturer is the floor, not the ceiling, and it only covers the physical pen. Private providers then price in (or quietly leave out) several other elements: the clinical consultation, the prescription itself, clinical re-review before each repeat, delivery, and ongoing prescriber access if you have questions between doses.
When a headline figure looks noticeably lower than the £149–£375 range you'll see across the market, it usually means at least one of those components is charged separately, or that the provider's safety infrastructure is thinner. A consultation fee of £30–£60, a prescription charge on top, and a delivery fee can turn an apparently modest per-pen price into something considerably higher by the time the pen arrives. Worth checking: look for a breakdown on any provider's pricing page before you read the number as a final figure.
If you want a straightforward answer to how much tirzepatide is likely to cost you, the total also depends on the dose, a 2.5mg starter pen sits at a different price point from a 15mg maintenance pen. For dose-specific detail on what those figures look like in practice, our tirzepatide cost overview and the individual pages for 5mg and 10mg break this down further. The dose you'll be prescribed is a clinical decision, starting at the lowest strength and titrating upward as your body adjusts is how the licensed schedule works.
A few things should be non-negotiable when you're comparing costs for a prescription-only medicine. The first is a genuine clinical assessment: a prescriber reviewing your health information, not a brief checkbox form that ticks itself. The second is a mechanism for ongoing oversight, if your dose needs to change, or you experience a side effect, there should be a real clinician available. The third is supply chain transparency: genuine Mounjaro (the UK brand for tirzepatide) arrives in the KwikPen format supplied by Eli Lilly through the licensed UK supply chain. The MHRA's Drug Safety Update communications and public enforcement activity make clear that fake pens have made their way into the UK market, counterfeit supplies have been found to contain incorrect substances, including insulin.
Reporting any suspect seller or product is straightforward through the MHRA's Yellow Card scheme. If a price looks far below the market range or the seller is operating through social media without directing you to a registered pharmacy, those are significant red flags, not a deal.
You can check whether any online pharmacy is registered in about thirty seconds by searching the GPhC pharmacy register; a legitimate provider will have a registration number you can verify there directly. That step costs nothing and takes less time than reading this paragraph.
Plainly: we are not the cheapest option, and that is a deliberate choice. The Mounjaro pricing at nume is one transparent figure that covers consultation, prescription, the medicine itself, and free next-working-day DPD delivery. There is no subscription. There is no auto-renewal. Every repeat order is clinically reviewed again before anything is dispatched, because the prescriber's job does not end at the first approval.
Our prescribers (you can read about our clinical oversight on the clinical team page) review consultations the same day. A real clinician reads your answers; the decision is theirs, not an algorithm's. That is the infrastructure behind the price, and it is what allows us to put our GPhC registration number on every page.
Current treatment pricing is displayed on the treatment page, where you can also start your free consultation. We do not print per-pen prices in body copy, and we do not run discount codes, voucher schemes or promotional offers, for a prescription medicine, that kind of marketing sits uneasily with clinical rigour. What we offer instead is a single honest figure and a service built around it.
For most purchases, price comparison is sensible. For a prescription-only injectable medicine, it is the second question, not the first. The right first question is whether you are receiving genuine medicine, assessed by a qualified prescriber, through a regulated and verifiable pharmacy. A small saving per pen is not a meaningful benefit if the supply chain is opaque or the clinical review amounts to a formality.
NICE's appraisal of tirzepatide (TA1026) and the broader NHS framework for weight-management medicines exist because clinical oversight matters, access to this class of medicine is meant to be mediated by a prescriber who knows your health history, not by whoever quotes the lowest number. The weight-loss treatments overview at nume sets out how we approach that, and our FAQs cover the questions our prescribers hear most often.
If you are ready to find out whether tirzepatide is clinically suitable for you, the consultation is free and takes a few minutes. Start your free consultation on the treatment page.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.